Share this video  

SABCS 2022 | Remaining questions regarding HER2-low breast cancer

Rani Bansal • 7 Dec 2022
SABCS 2022
Breast Cancer
Molecular Profiling

More from Rani Bansal

0:32
Highlights in HER2-low breast cancer at SABCS 2022
Rani Bansal • 7 Dec 2022
1:26
Genomic and transcriptomic landscape of HER2-low breast cancer
Rani Bansal • 7 Dec 2022
0:45
The evolution of HER2-low breast cancer from primary to recurrence
Rani Bansal • 7 Dec 2022

Related Videos

2:52
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
Peter Schmid • 21 Oct 2018
1:52
What impact will biosimilars have on clinical life?
Diana Lüftner • 21 Sep 2017
1:22
Drug shortages around the world: why communication is key
Fatima Cardoso • 22 Sep 2017
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty • 5 Nov 2019
The content of VJOncology is intended for healthcare professionals